NAS10026,990+1.35%S&P7,377+0.31%GOLD$4,075−0.94%BTC$75,727−0.03%VIX25.64−9.01%latest tape · as of 18:05 UTC
The Screen · Utilities · Utilities - Regulated Gas
Brookfield Infrastructure Corporation
BIPC · the NYSE · USD · Market cap $4.7B
Brookfield Infrastructure Corporation, together with its subsidiaries, owns and operates utility investments in Brazil, the United Kingdom, and internationally.
FAIL · Does not pass the screen
39.66 USD
Price as of 6 Nov 2026Daily close, not a live quote
Screened 2026-11-06 · the tape above runs as of 18:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price39.66 USD at the 6 Nov 2026 close
Fair value32.62. Our model only; only one analyst covers it, too few to cross-check it.
Our value readOvervalued vs our fair value, as of 6 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.74, read 2026-11-02
Ethical does not pass the values gate
Price39.66 USD
Fair value32.62Our model only; only one analyst covers it, too few to cross-check it.
Ethical score70.0/100
Value readOvervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-11-06Read Markdown37.92+4.6% to today Accumulation gives way to Markdown first Markdown read since October
2026-10-18Read Accumulation37.63+5.4% to today ✓Markup gives way to Accumulation with volume flow in agreement
2026-10-11Read Markup35.92+10.4% to today ✓Markdown gives way to Markup first Markup read since July
2026-10-02Read Markdown35.92+10.4% to today Distribution gives way to Markdown after a 9% slide in 6 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Brookfield Infrastructure Corporation holds its Accumulation at $39.66. Consolidating, no directional conviction, held for 96 days.
As held on the ledger · 2026-11-06
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 96 days
Price at the screen
$39.66
Valuation
N/A trailing · 18.82 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.33
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
55.23%
Below 33%
Interest-bearing debt is 55.2% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.05%
Below 33%
Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit.
Pass
Receivables
4.94%
Below 49%
Money owed to the company is 4.9% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Brookfield Infrastructure's business is in a permissible area, but its interest-bearing debt is about 55% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BIPC's ethical verdict changes
Today BIPC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our model only; only one analyst covers it, too few to cross-check it.
Our analysis reads Overvalued vs our fair value, as of 6 Nov 2026: it trades above our $32.62 fair value estimate, 8.50% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. The price runs 21.6% above the base estimate.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $32.62, with a range of $32.62 to $37.51, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Regulated gas lines rarely justify stretched multiples
Picture a pipeline carrying Brazilian gas receipts across borders and into UK homes. That network sounds essential until the numbers reveal shrinking revenue, deep losses and a negative return on equity. We pass because the current price sits well above our fair value estimate, leaving no margin of safety and a forward multiple that already prices in perfection the business has not delivered.
The cyclical nature of energy infrastructure adds another layer. Peak earnings often coincide with low multiples that later prove expensive once volumes or tariffs normalise. Here the multiple is already elevated while growth has turned negative, so any recovery story carries the classic trap of mistaking a temporary upswing for durable improvement.
Currency swings, regulatory resets and single-analyst coverage further widen the range of outcomes. Ethical screens are cleared, yet the financial picture offers no compelling case to step in.
Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BIPC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-06Markdown · changed$37.92-1.2%Entry 17
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-05Accumulation$38.39+2.1%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Accumulation$37.61+0.3%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Accumulation$37.49+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Accumulation$37.49+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Accumulation$37.49+1.5%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Accumulation$36.94+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Accumulation$36.94-0.3%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$37.05-1.5%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it sell, with a mean price target of $46.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
